BioMarker Strategies Nabs $200K NCI Grant, Raises $2.3M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cancer diagnostics firm BioMarker Strategies today announced it has received a $200,000 Small Business Innovation Research grant to develop a pathway-based companion diagnostic test for drug inhibitors targeting the ErbB signal transduction network.

The Baltimore, MD-based firm also disclosed that it raised $2.3 million in equity financing last month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.